SCHEMBL7859609

SCHEMBL7859609

CCN1C(=O)/C(=C/c2ccc(/C=C3\SC(=S)C(C)C3=O)s2)SC1=S

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNFRSF1A P19438 1/20 0.49
▸ ALDH1A1 P00352 10/20 0.49
▸ MEN1 O00255 4/20 0.48
▸ MAPT P10636 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ RAB9A P51151 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ IDE P14735 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ TNNI3 P19429 1/20 0.47
▸ TNNT2 P45379 1/20 0.47
▸ TNNC1 P63316 1/20 0.47
▸ PDE4B Q07343 2/20 0.46
▸ DNM1 Q05193 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25165760 0.80 TNFRSF1A (0.62) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL3135718 0.75 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL3135706 0.75 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL3135714 0.75 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL7860609 0.73 TNFRSF1A (0.55) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL25165309 0.72 TNFRSF1A (0.59) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL1907110 0.72 PTPN22 (0.53) ALDH1A1MEN1MAPTKMT2APOLB
SCHEMBL1907114 0.72 PTPN22 (0.53) ALDH1A1MEN1MAPTKMT2APOLB
SCHEMBL24129903 0.72 CISD1 (0.67) ALDH1A1MEN1MAPTKMT2AMAPK1
SCHEMBL2447131 0.72 CISD1 (0.67) ALDH1A1MEN1MAPTKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 TNFRSF1A 212/4885ALDH1A1 4227/4885MEN1 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback